Jeffrey Ostrove
Chief Executive Officer at Stelios Therapeutics, Inc.
Profile
Jeffrey M.
Ostrove is the founder of Magenta Corp.
He currently holds the position of Director at the Biotechnology Innovation Organization, Director at Locanabio, Inc., Director at Paros Bio, Inc., and Chief Executive & Financial Officer, Secretary at Stelios Therapeutics, Inc. Previously, he served as President & Chief Executive Officer at Ceregene, Inc. for a brief period in 2001.
From 2014 to 2016, he was the Chief Executive Officer & Director at AbVitro LLC.
He also held positions as Chief Operating Officer at Medigene, Inc., and as a Principal at both the National Institutes of Health and the National Institute of Allergy & Infectious Diseases.
Dr. Ostrove obtained a doctorate degree from the University of Florida.
Jeffrey Ostrove active positions
| Companies | Position | Start |
|---|---|---|
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Director/Board Member | - |
Locanabio, Inc.
 Locanabio, Inc. Packaged SoftwareTechnology Services Locana, Inc. engages in the provision of ribonucleic acid targeting gene therapy. Its platform technology addresses a wide spectrum of human genetic diseases. It has advanced a powerful modular RNA targeting-effector approach to optimize and advance therapeutic candidates that is distinct from DNA-targeted approaches and nucleic acid-based RNA targeting. The company was founded by Gene Yeo and David Nelles in 2016 and is headquartered in San Diego, CA. | Director/Board Member | 22/05/2019 |
Stelios Therapeutics, Inc.
 Stelios Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Lexeo Therapeutics, Inc., Stelios Therapeutics, Inc. is a company that develops novel adeno-associated virus based gene therapies for rare genetic cardiac conditions. The company is based in Cardiff, CA. The company was founded by Eric Adler and Farah Sheikh. The CEO is Jeffrey M. Ostrove. Stelios Therapeutics was acquired by Lexeo Therapeutics, Inc. on July 21, 2021. | Chief Executive Officer | 01/12/2016 |
Paros Bio, Inc.
 Paros Bio, Inc. BiotechnologyHealth Technology Paros Bio, Inc. is a company that specializes in gene therapy for neurodegenerative diseases. The company is based in Boston, MA. Specifically, they are developing a gene replacement approach to treat autosomal dominant Alzheimer's disease caused by mutations in the presenilin 1 gene. The company's therapy directly addresses the underlying genetic cause of the disease. | Director/Board Member | - |
Former positions of Jeffrey Ostrove
| Companies | Position | End |
|---|---|---|
AbVitro LLC
 AbVitro LLC BiotechnologyHealth Technology AbVitro LLC provided an antibody discovery platform. The company was founded by George W. Church, Uri Laserson, Mirza Cifric and Francois Vigneault in 2010 and headquartered in Seattle, WA. | Chief Executive Officer | 01/01/2016 |
| National Institute of Allergy & Infectious Diseases | Corporate Officer/Principal | - |
Magenta Corp.
 Magenta Corp. Industrial MachineryProducer Manufacturing Magenta Corp. manufactures plastic injection molds. The American company was founded by Jeffrey M. Ostrove. | Founder | 29/01/2010 |
National Institutes of Health
 National Institutes of Health General GovernmentGovernment National Institutes Of Health conducts & supports peer-reviewed medical research and science. The firm's scientists & researchers investigate on different ways to prevent diseases as well as the causes, treatments and cures for common and rare diseases. The company was founded in 1887 and is headquartered in Bethesda, MD. | Corporate Officer/Principal | - |
MediGene, Inc.
 MediGene, Inc. Pharmaceuticals: MajorHealth Technology MediGene, Inc. develops herpes simplex virus technologies for the treatment of tumors and for gene delivery. The company was founded by Ram Bhatt and Frank Tufaro and is headquartered in San Diego, CA. | Chief Operating Officer | - |
Training of Jeffrey Ostrove
| University of Florida | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 10 |
|---|---|
Ceregene, Inc.
 Ceregene, Inc. Pharmaceuticals: MajorHealth Technology Ceregene, Inc. develops pharmaceutical products for neurodegenerative disorders. The company was founded in January 2001 and it is headquartered in Richmond, CA. | Health Technology |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Commercial Services |
AbVitro LLC
AbVitro LLC BiotechnologyHealth Technology AbVitro LLC provided an antibody discovery platform. The company was founded by George W. Church, Uri Laserson, Mirza Cifric and Francois Vigneault in 2010 and headquartered in Seattle, WA. | Health Technology |
MediGene, Inc.
MediGene, Inc. Pharmaceuticals: MajorHealth Technology MediGene, Inc. develops herpes simplex virus technologies for the treatment of tumors and for gene delivery. The company was founded by Ram Bhatt and Frank Tufaro and is headquartered in San Diego, CA. | Health Technology |
National Institutes of Health
National Institutes of Health General GovernmentGovernment National Institutes Of Health conducts & supports peer-reviewed medical research and science. The firm's scientists & researchers investigate on different ways to prevent diseases as well as the causes, treatments and cures for common and rare diseases. The company was founded in 1887 and is headquartered in Bethesda, MD. | Government |
| National Institute of Allergy & Infectious Diseases | Government |
Magenta Corp.
Magenta Corp. Industrial MachineryProducer Manufacturing Magenta Corp. manufactures plastic injection molds. The American company was founded by Jeffrey M. Ostrove. | Producer Manufacturing |
Locanabio, Inc.
Locanabio, Inc. Packaged SoftwareTechnology Services Locana, Inc. engages in the provision of ribonucleic acid targeting gene therapy. Its platform technology addresses a wide spectrum of human genetic diseases. It has advanced a powerful modular RNA targeting-effector approach to optimize and advance therapeutic candidates that is distinct from DNA-targeted approaches and nucleic acid-based RNA targeting. The company was founded by Gene Yeo and David Nelles in 2016 and is headquartered in San Diego, CA. | Technology Services |
Stelios Therapeutics, Inc.
Stelios Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Lexeo Therapeutics, Inc., Stelios Therapeutics, Inc. is a company that develops novel adeno-associated virus based gene therapies for rare genetic cardiac conditions. The company is based in Cardiff, CA. The company was founded by Eric Adler and Farah Sheikh. The CEO is Jeffrey M. Ostrove. Stelios Therapeutics was acquired by Lexeo Therapeutics, Inc. on July 21, 2021. | Health Technology |
Paros Bio, Inc.
Paros Bio, Inc. BiotechnologyHealth Technology Paros Bio, Inc. is a company that specializes in gene therapy for neurodegenerative diseases. The company is based in Boston, MA. Specifically, they are developing a gene replacement approach to treat autosomal dominant Alzheimer's disease caused by mutations in the presenilin 1 gene. The company's therapy directly addresses the underlying genetic cause of the disease. | Health Technology |
- Stock Market
- Insiders
- Jeffrey Ostrove
